Priority Life Care Selects ECP to Power an AI-Forward Clinical Transformation Across 60+ Communities

PLC partners with a modern, data-driven clinical platform to enhance resident care, streamline staff workflows, and support scalable growth MILWAUKEE–(BUSINESS WIRE)–#assistedliving—Priority Life Care (PLC), a senior living provider serving more than 4,000 residents across 60+ communities, today announced a major investment in its technology infrastructure through a new enterprise partnership with ECP. ECP is the … [Read more…]

Priority Health and Group Health Cooperative of Eau Claire Finalize Transaction to Expand Access to High-Quality Care

Priority Health becomes four-state health plan GRAND RAPIDS, Mich.–(BUSINESS WIRE)–Priority Health, a Michigan-based health plan serving more than 1.3 million members, has completed a transaction with Group Health Cooperative of Eau Claire (the Cooperative), a community-based health plan in Wisconsin serving more than 61,000 members, that establishes Priority Health as the sole governing member of … [Read more…]

Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

BOSTON–(BUSINESS WIRE)–Seaport Therapeutics (“Seaport” or the “Company”), a clinical-stage therapeutics company that is advancing novel neuropsychiatric medicines with a proven strategy and team, today announced that Daphne Zohar, Co-Founder and Chief Executive Officer, will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 9:30 a.m. PST. Ms. Zohar will … [Read more…]

Orum Therapeutics Appoints Chad May as Chief Scientific Officer to Drive Degrader-Antibody Conjugate Innovation and Programs

BOSTON & DAEJEON, South Korea–(BUSINESS WIRE)–#ADC—Orum Therapeutics (Orum or the Company) (KRX: 475830), a biotechnology company pioneering the field of degrader-antibody conjugates (DACs), today announced the appointment of Chad May, Ph.D., as Chief Scientific Officer (CSO). Dr. May brings more than 20 years of oncology and immunology research experience with a track record of advancing … [Read more…]

SINOVAC Provides Update on Antigua High Court Order and Auditor Engagement

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today provided an update on the Antigua High Court’s interlocutory order governing the Company’s board composition and corporate actions pending trial, and announced the engagement of Zhonghua Certified Public Accountants LLP (“Zhonghua”), an affiliate of the global … [Read more…]

Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year Report

BEIJING–(BUSINESS WIRE)–Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, 2026 (the “Notification Letter”) from Nasdaq Listing Qualifications (“Nasdaq”), stating that the Company was not in compliance with Nasdaq’s Listing Rule 5250(c)(2) since the Company … [Read more…]

Bausch + Lomb Completes Refinancing of Outstanding Term B Loans

VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb” or the “company”), a leading global eye health company dedicated to helping people see better to live better, today announced that it closed the previously announced credit agreement refinancing. In connection with the closing, Bausch + Lomb has entered into a fourth amendment (the … [Read more…]

Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st – Jan 22nd, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st – Jan 22nd, 2026)” training has been added to ResearchAndMarkets.com’s offering. Enhance your knowledge in protein engineering to understand how to advance therapeutic development and industrial applications. Protein-based therapeutics have significantly advanced and created new paradigms in disease treatment. Half of the top ten … [Read more…]

Successful Medical Writing from Protocol to CTD Training Course: Understand International Guidelines and Standards (Mar 23rd – Mar 24th, 2026) – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Successful Medical Writing – from Protocol to CTD Training Course (Mar 23rd – Mar 24th, 2026)” training has been added to ResearchAndMarkets.com’s offering. Success in the pharmaceutical industry depends on the speed and efficiency of new drug approvals. This process largely relies on the quality of documentation submitted to the regulatory authorities, and … [Read more…]

Cell Therapy Processing Global Markets and Technology Analysis Report 2025-2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cell Therapy Processing: Global Markets and Technologies” report has been added to ResearchAndMarkets.com’s offering. The global market for cell therapy processing is estimated to grow from $2.7 billion in 2025 to reach $7.1 billion by 2030, at a compound annual growth rate (CAGR) 21.4% from 2025 to 2030. According to the American Society … [Read more…]